PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review)

  • Authors:
    • Nana Tokuhira
    • Yasuko Kitagishi
    • Miho Suzuki
    • Akari Minami
    • Atsuko Nakanishi
    • Yuna Ono
    • Keiko Kobayashi
    • Satoru Matsuda
    • Yasunori Ogura
  • View Affiliations

  • Published online on: October 27, 2014     https://doi.org/10.3892/ijmm.2014.1981
  • Pages: 10-16
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The pathogenesis of inflammatory bowel disease (IBD), including Crohn's disease, is a subject of increasing interest. Loss-of-function mutations in nucleotide‑binding oligomerization domain-containing protein 2 (NOD2) are strong genetic factors linked to Crohn's disease, which eventually leads to an excessive mucosal inflammatory response directed against components of normal gut microbiota. Reactive oxygen species (ROS) play an important role in inflammation processes, as well as in transduction of signals from receptors for several cytokines, such as tumor necrosis factor α (TNFα). ROS activate nuclear factor‑κB (NF‑κB) via IκB kinase (IKK) through the PI3K/AKT/PTEN pathway. Therefore, this pathway is recognized to play a key role in Crohn's disease. Loss of function has been demonstrated to occur as an early event in a wide variety of diseases. Given this prevalent involvement in a number of diseases, the molecular development that modulates this pathway has been the subject of several studies. In addition, it has been the focus of extensive research and drug discovery activities. A better understanding of the molecular assemblies may reveal novel targets for the therapeutic development against Crohn's disease.
View Figures
View References

Related Articles

Journal Cover

January-2015
Volume 35 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tokuhira N, Kitagishi Y, Suzuki M, Minami A, Nakanishi A, Ono Y, Kobayashi K, Matsuda S and Ogura Y: PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review). Int J Mol Med 35: 10-16, 2015.
APA
Tokuhira, N., Kitagishi, Y., Suzuki, M., Minami, A., Nakanishi, A., Ono, Y. ... Ogura, Y. (2015). PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review). International Journal of Molecular Medicine, 35, 10-16. https://doi.org/10.3892/ijmm.2014.1981
MLA
Tokuhira, N., Kitagishi, Y., Suzuki, M., Minami, A., Nakanishi, A., Ono, Y., Kobayashi, K., Matsuda, S., Ogura, Y."PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review)". International Journal of Molecular Medicine 35.1 (2015): 10-16.
Chicago
Tokuhira, N., Kitagishi, Y., Suzuki, M., Minami, A., Nakanishi, A., Ono, Y., Kobayashi, K., Matsuda, S., Ogura, Y."PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review)". International Journal of Molecular Medicine 35, no. 1 (2015): 10-16. https://doi.org/10.3892/ijmm.2014.1981